1. |
Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after D2 gastrectomy for gastric cancer. J Clin Oncol, 2012, 30(31): 3834-3840.
|
2. |
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase Ⅲ trial. J Clin Oncol, 2011, 29(13): 1715-1721.
|
3. |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355(1): 11-20.
|
4. |
Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet, 2019, 393(10184): 1948-1957.
|
5. |
Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2. 2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2022, 20(2): 167-192.
|
6. |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer, 2023, 26(1): 1-25.
|
7. |
Reddavid R, Sofia S, Chiaro P, et al. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?. World J Gastroenterol, 2018, 24(2): 274-289.
|
8. |
You X, Zhou Q, Song J, et al. Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy. BMC Cancer, 2019, 19(1): 931. doi: 10.1186/s12885-019-6143-x.
|
9. |
Radulescu D, Baleanu VD, Padureanu V, et al. Neutrophil/lymphocyte ratio as predictor of anastomotic leak after gastric cancer surgery. Diagnostics (Basel), 2020, 10(10): 799. doi: 10.3390/diagnostics10100799.
|
10. |
Mungan İ, Dicle ÇB, Bektaş Ş, et al. Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?. Mil Med Res, 2020, 7(1): 9. doi: 10.1186/s40779-020-00234-y.
|
11. |
Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol, 2014, 20(30): 10537-10544.
|
12. |
Cheung CW, Ng KF, Liu J, et al. Analgesic and sedative effects of intranasal dexmedetomidine in third molar surgery under local anaesthesia. Br J Anaesth, 2011, 107(3): 430-437.
|
13. |
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg, 2009, 250(2): 187-196.
|
14. |
Liu Z, Liang Y, Tang X, et al. Decrease in blood neutrophil-to-lymphocyte ratio indicates better survival after neoadjuvant chemotherapy in patients with advanced gastric cancer. Front Surg, 2021, 8: 745748. doi: 10.3389/fsurg.2021.745748.
|
15. |
Gong W, Zhao L, Dong Z, et al. After neoadjuvant chemotherapy platelet/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients. J Clin Lab Anal, 2018, 32(5): e22364. doi: 10.1002/jcla.22364.
|
16. |
Nakauchi M, Vos EL, Tang LH, et al. Association of obesity with worse operative and oncologic outcomes for patients undergoing gastric cancer resection. Ann Surg Oncol, 2021, 28(12): 7040-7050.
|
17. |
Zhang Y, Li Z, Jiang L, et al. Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment. Nutrition, 2021, 85: 111135. doi: 10.1016/j.nut.2020.111135.
|
18. |
Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol, 2022, 75(1): 25-36.
|
19. |
Dong QT, Cai HY, Zhang Z, et al. Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: a comprehensive analysis from a large-scale prospective study. Clin Nutr, 2021, 40(5): 3360-3369.
|
20. |
Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol, 2013, 88(1): 218-230.
|
21. |
Li QG, Li P, Tang D, et al. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol, 2013, 19(25): 4060-4065.
|
22. |
Zhang Y, Lu JJ, Du YP, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine (Baltimore), 2018, 97(12): e0144. doi: 10.1097/MD.0000000000010144.
|
23. |
Hamilton TD, Mahar AL, Haas B, et al. The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis. Gastric Cancer, 2018, 21(4): 710-719.
|
24. |
Watanabe M, Iwatsuki M, Iwagami S, et al. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg, 2012, 36(7): 1632-1639.
|
25. |
Aoyama T, Yoshikawa T, Watanabe T, et al. Macroscopic tumor size as an independent prognostic factor for stage Ⅱ/Ⅲ gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. Gastric Cancer, 2011, 14(3): 274-278.
|
26. |
Shiraishi N, Sato K, Yasuda K, et al. Multivariate prognostic study on large gastric cancer. J Surg Oncol, 2007, 96(1): 14-18.
|
27. |
Park JM, Jin SH, Lee SR, et al. Complications with laparoscopically assisted gastrectomy: multivariate analysis of 300 consecutive cases. Surg Endosc, 2008, 22(10): 2133-2139.
|
28. |
Wang X, Yao Y, Qian H, et al. Longer operating time during gastrectomy has adverse effects on short-term surgical outcomes. J Surg Res, 2019, 243: 151-159.
|
29. |
Inaoka K, Kanda M, Uda H, et al. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol, 2017, 23(14): 2519-2526.
|
30. |
Pang W, Lou N, Jin C, et al. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol, 2016, 28(5): 493-502.
|